141 related articles for article (PubMed ID: 20923331)
1. Antitumor activity of glycosylated molluscan hemocyanins via Guerin ascites tumor.
Dolashka P; Velkova L; Iliev I; Beck A; Dolashki A; Yossifova L; Toshkova R; Voelter W; Zacharieva S
Immunol Invest; 2011; 40(2):130-49. PubMed ID: 20923331
[TBL] [Abstract][Full Text] [Related]
2. Identification of glycosylated sites in Rapana hemocyanin by mass spectrometry and gene sequence, and their antiviral effect.
Dolashka-Angelova P; Lieb B; Velkova L; Heilen N; Sandra K; Nikolaeva-Glomb L; Dolashki A; Galabov AS; Van Beeumen J; Stevanovic S; Voelter W; Devreese B
Bioconjug Chem; 2009 Jul; 20(7):1315-22. PubMed ID: 19499947
[TBL] [Abstract][Full Text] [Related]
3. Changes in the gene expression profile of the bladder cancer cell lines after treatment with Helix lucorum and Rapana venosa hemocyanin.
Antonova O; Yossifova L; Staneva R; Stevanovic S; Dolashka P; Toncheva D
J BUON; 2015; 20(1):180-7. PubMed ID: 25778314
[TBL] [Abstract][Full Text] [Related]
4. Immunological potential of Helix vulgaris and Rapana venosa hemocyanins.
Dolashka-Angelova P; Stefanova T; Livaniou E; Velkova L; Klimentzou P; Stevanovic S; Salvato B; Neychev H; Voelter W
Immunol Invest; 2008; 37(8):822-40. PubMed ID: 18991098
[TBL] [Abstract][Full Text] [Related]
5. Marine gastropod hemocyanins as adjuvants of non-conjugated bacterial and viral proteins.
Gesheva V; Idakieva K; Kerekov N; Nikolova K; Mihaylova N; Doumanova L; Tchorbanov A
Fish Shellfish Immunol; 2011 Jan; 30(1):135-42. PubMed ID: 20887791
[TBL] [Abstract][Full Text] [Related]
6. Glycan structures and antiviral effect of the structural subunit RvH2 of Rapana hemocyanin.
Dolashka P; Velkova L; Shishkov S; Kostova K; Dolashki A; Dimitrov I; Atanasov B; Devreese B; Voelter W; Van Beeumen J
Carbohydr Res; 2010 Nov; 345(16):2361-7. PubMed ID: 20863484
[TBL] [Abstract][Full Text] [Related]
7. [Hemocyanins as immunostimulants].
Del Campo M; Arancibia S; Nova E; Salazar F; González A; Moltedo B; De Ioannes P; Ferreira J; Manubens A; Becker MI
Rev Med Chil; 2011 Feb; 139(2):236-46. PubMed ID: 21773663
[TBL] [Abstract][Full Text] [Related]
8. Selective Cytotoxicity and Changes in Protein Expression of T24 Bladder Carcinoma Permanent Cell Line after Treatment with Hemocyanins.
Dolashki A; Antonova O; Velkova L; Kaynarov D; Voelter W; Dolashka P
Curr Med Chem; 2022; 29(42):6479-6498. PubMed ID: 35993464
[TBL] [Abstract][Full Text] [Related]
9.
Salazar ML; Jiménez JM; Villar J; Rivera M; Báez M; Manubens A; Becker MI
J Biol Chem; 2019 Dec; 294(51):19546-19564. PubMed ID: 31719148
[TBL] [Abstract][Full Text] [Related]
10. Marine tumor vaccine carriers: structure of the molluscan hemocyanins KLH and htH.
Markl J; Lieb B; Gebauer W; Altenhein B; Meissner U; Harris JR
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R3-9. PubMed ID: 11768622
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins.
Moltedo B; Faunes F; Haussmann D; De Ioannes P; De Ioannes AE; Puente J; Becker MI
J Urol; 2006 Dec; 176(6 Pt 1):2690-5. PubMed ID: 17085197
[TBL] [Abstract][Full Text] [Related]
12.
Boyanova O; Dolashka P; Toncheva D; Rammensee HG; Stevanović S
Biomed Rep; 2013 Mar; 1(2):235-238. PubMed ID: 24648926
[TBL] [Abstract][Full Text] [Related]
13. N-glycan structures of β-HlH subunit of Helix lucorum hemocyanin.
Velkova L; Dolashka P; Van Beeumen J; Devreese B
Carbohydr Res; 2017 Sep; 449():1-10. PubMed ID: 28672164
[TBL] [Abstract][Full Text] [Related]
14. Oligomeric stability of Rapana venosa hemocyanin (RvH) and its structural subunits.
Dolashka-Angelova P; Schwarz H; Dolashki A; Stevanovic S; Fecker M; Saeed M; Voelter W
Biochim Biophys Acta; 2003 Mar; 1646(1-2):77-85. PubMed ID: 12637014
[TBL] [Abstract][Full Text] [Related]
15. Structure of hemocyanin from garden snail Helix lucorum.
Velkova L; Dimitrov I; Schwarz H; Stevanovic S; Voelter W; Salvato B; Dolashka-Angelova P
Comp Biochem Physiol B Biochem Mol Biol; 2010 Sep; 157(1):16-25. PubMed ID: 20433940
[TBL] [Abstract][Full Text] [Related]
16. From Ocean to Bedside: the Therapeutic Potential of Molluscan Hemocyanins.
Zanjani NT; Saksena MM; Dehghani F; Cunningham AL
Curr Med Chem; 2018; 25(20):2292-2303. PubMed ID: 28464782
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of Rapana thomasiana hemocyanin. Comparison with other prosobranch (gastropod) hemocyanins.
Idakieva K; Stoeva S; Voelter W; Gielens C
Comp Biochem Physiol B Biochem Mol Biol; 2004 Jul; 138(3):221-8. PubMed ID: 15253870
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation sites of hemocyanins of Helix pomatia and Sepia officinalis.
Gielens C; De Geest N; Compernolle F; Préaux G
Micron; 2004; 35(1-2):99-100. PubMed ID: 15036305
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and carrier properties of novel hemocyanins coupled to a mimotope of GD2 ganglioside.
Palacios M; Tampe R; Del Campo M; Zhong TY; López MN; Salazar-Onfray F; Becker MI
Eur J Med Chem; 2018 Apr; 150():74-86. PubMed ID: 29524730
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer.
Mora Román JJ; Del Campo M; Villar J; Paolini F; Curzio G; Venuti A; Jara L; Ferreira J; Murgas P; Lladser A; Manubens A; Becker MI
J Immunol Res; 2019; 2019():7076942. PubMed ID: 30847353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
